Martin Feth

Title: Martin Feth: Innovator in Pharmaceutical Chemistry

Introduction

Martin Feth is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 3 patents to his name, Feth's work focuses on improving treatments for various medical conditions.

Latest Patents

Feth's latest patents include advancements in crystalline salts of R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1H-imidazol-4-yl)-propionic acid. This invention relates to a sodium salt of the compound, which is available in crystalline form or as a monohydrate or anhydrate. The patent outlines a process for preparing this salt and methods for using it to treat conditions that can be improved by administering an inhibitor of the enzyme TAFIa (activated thrombin-activatable fibrinolysis inhibitor).

Career Highlights

Martin Feth is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the pharmaceutical industry. Feth's expertise in the field has positioned him as a valuable asset to his team and the company.

Collaborations

Throughout his career, Feth has collaborated with notable colleagues, including Norbert Nagel and Bruno Baumgartner. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Martin Feth is a distinguished inventor whose work in pharmaceutical chemistry has led to significant innovations. His contributions, particularly in the area of crystalline salts, demonstrate his commitment to improving medical treatments. Feth's ongoing work at Sanofi continues to impact the field positively.